[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-336501-105":59,"doc-detail-336501-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","hipk2-in-colon-cancer-a-potential-biomarker-for-tumor-progression-and-response-to-therapies","HIPK2 in Colon Cancer - A Potential Biomarker for Tumor Progression and Response to Therapies","","Colon cancer is among the most common and fatal malignancies worldwide, driven by stepwise accumulation of genetic alterations in tumor suppressor genes and oncogenes that promote tumor growth and metastasis. HIPK2, a serine/threonine protein kinase and oncosuppressor, inhibits tumor progression mainly via apoptosis promotion, whereas loss can increase tumorigenicity and therapy resistance. HIPK2 modulates pathways controlling proliferation, invasion, angiogenesis, inflammation and hypoxia, including p53, Wnt/β-catenin and NRF2-related signaling, and shapes tumor–host interactions within the tumor microenvironment; this review evaluates HIPK2 roles and underlying mechanisms to support novel therapeutic strategies.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/hipk2-in-colon-cancer-a-potential-biomarker-for-tumor-progression-and-response-to-therapies/336501/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/hipk2-in-colon-cancer-a-potential-biomarker-for-tumor-progression-and-response-to-therapies/336501.png","ImageObject",300,407,{"name":92,"@type":93},"Noah","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main focus of the review regarding HIPK2 in colon cancer?","Question",{"text":112,"@type":113},"The review assesses the role of HIPK2 in colon cancer and the molecular pathways that explain its involvement in carcinogenesis and response to therapies.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does HIPK2 influence tumor growth and therapy response?",{"text":117,"@type":113},"HIPK2 activation suppresses tumor growth primarily by promoting apoptosis, while its inactivation can increase tumorigenicity and resistance to therapies.",{"name":119,"@type":110,"acceptedAnswer":120},"Which molecular pathways are described as being connected to HIPK2 in colon cancer?",{"text":121,"@type":113},"The document highlights HIPK2 participation in pathways including p53, Wnt/β-catenin, and NRF2-related signaling, along with effects on processes such as invasion, angiogenesis, inflammation, and hypoxia.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},336501,1791014219,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},8796095462418,"https://ap-avatar.wpscdn.com/avatar/80000253c1241d02b47?x-image-process=image/resize,m_fixed,w_180,h_180&k=1778826106357471780","Review  \nHIPK2 in Colon Cancer: A Potential Biomarker for Tumor Progression and Response to Therapies  \nAlessandra Verdina 1, Alessia Garufi 1, Valerio D’Orazi 2 and Gabriella D’Orazi 1,3, *  \nCitation: Verdina, A.; Garufi, A.; D’Orazi, V.; D’Orazi, G. HIPK2 in Colon Cancer: A Potential Biomarker for Tumor Progression and Response to Therapies. Int. J. Mol. Sci. 2024, 25, 7678. [https://doi.org/10.3390/](https://doi.org/10.3390/)[ ](https://doi.org/10.3390/)ijms25147678  \nAcademic Editor: Ion Cristóbal  \nReceived: 24 June 2024  \nRevised: 10 July 2024  \nAccepted: 11 July 2024  \nPublished: 12 July 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 Unit of Cellular Networks and Molecular Therapeutic Targets, IRCCS Regina Elena National Cancer Institute, 00144 Rome, Italy; [alessandra.verdina@ifo.it](alessandra.verdina@ifo.it) (A.V.); [alessia.garufi@ifo.it](alessia.garufi@ifo.it) (A.G.)  \n2 Department of Surgery, Sapienza University, 00185 Rome, Italy; [valerio.dorazi@uniroma1.it](valerio.dorazi@uniroma1.it)  \n[3](3 Department of Neurosciences)[ Department of Neurosciences](3 Department of Neurosciences), [Imaging and Clinical Sciences](Imaging and Clinical Sciences), [University](University) “[G. D](G. D)’[Annunzio](Annunzio)”, 66013 Chieti, Italy  \n* Correspondence: [gdorazi@unich.it](gdorazi@unich.it)  \nAbstract: Colon cancer, one of the most common and fatal cancers worldwide, is characterized by stepwise accumulation of specific genetic alterations in tumor suppressor genes or oncogenes, leading to tumor growth and metastasis. HIPK2 (homeodomain-interacting protein kinase 2) is aserine/threonine protein kinase and a “bona fide” oncosuppressor protein. Its activation inhibits tumor growth mainly by promoting apoptosis, while its inactivation increases tumorigenicity and resistance to therapies of many different cancer types, including colon cancer. HIPK2 interacts with many molecular pathways by means of its kinase activity or transcriptional co-repressor function modulating cell growth and apoptosis, invasion, angiogenesis, inflammation and hypoxia. HIPK2 has been shown to participate in several molecular pathways involved in colon cancer including p53, Wnt/β-catenin and the newly identified nuclear factor erythroid 2 (NF-E2) p45-related factor 2  \n(NRF2) . HIPK2 also plays a role in tumor–host interaction in the tumor microenvironment (TME) by inducing angiogenesis and cancer-associated fibroblast (CAF) differentiation. The aim of this review is to assess the role of HIPK2 in colon cancer and the underlying molecular pathways for a better understanding of its involvement in colon cancer carcinogenesis and response to therapies, which will likely pave the way for novel colon cancer therapies.  \nKeywords: HIPK2; p53; colorectal cancer; colon cancer; hypoxia; hyperglycemia; cancer therapy; Wnt/β-catenin; NRF2; microRNA; angiogenesis; tumor inflammation  \n1. Introduction  \nColorectal cancer (herein, colon cancer), which comprises colon and/or rectum cancer, is one of the most common cancers in women and men: it is the third most frequently diagnosed type of cancer (11% of all diagnosed cancer cases) and the second leading cause of cancer-related mortality worldwide [1,2] . The 5-year survival rate depends on the tumor stage, ranging from 90% for the localized stage to 71% for regional and 14% for patients with distant metastasis [3] . Thus, early detection of the disease is a priority. In addition, a worrying rise in patients presenting with colon cancer younger than 50 years has been observed [4] . There are three principal types of colon cancer: sporadic, hereditary and colitis-associated. Global incidence and mor","cbCaik8uWAYPAjAp","https://ap.wps.com/l/cbCaik8uWAYPAjAp","pdf",875293,18,"English","# Abstract\n# Keywords\n# 1. Introduction\n## Figure 1. Risk factors for colon cancer development\n## Figure 2. Multistep carcinogenesis model","[{\"question\":\"What is the main focus of the review regarding HIPK2 in colon cancer?\",\"answer\":\"The review assesses the role of HIPK2 in colon cancer and the molecular pathways that explain its involvement in carcinogenesis and response to therapies.\"},{\"question\":\"How does HIPK2 influence tumor growth and therapy response?\",\"answer\":\"HIPK2 activation suppresses tumor growth primarily by promoting apoptosis, while its inactivation can increase tumorigenicity and resistance to therapies.\"},{\"question\":\"Which molecular pathways are described as being connected to HIPK2 in colon cancer?\",\"answer\":\"The document highlights HIPK2 participation in pathways including p53, Wnt/β-catenin, and NRF2-related signaling, along with effects on processes such as invasion, angiogenesis, inflammation, and hypoxia.\"}]","HIPK2 in Colon Cancer - A Potential Biomarker for Tumor Progression and Response to Therapies | PDF",1790015360,45,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d4d8ea212181c452173addac8265b6e9.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fdf9c1e29bbe50348163460ec8d36b7d.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/977edc2c91b53f7f146c03091e004b48.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d706eb1db20e338dcff8cd330eaca16d.webp",980,1385]